SCHEMBL7349262

SCHEMBL7349262

O=CNC1Cc2ccccc2N(C=O)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 5/20 0.36
MTNR1B P49286 5/20 0.36
SLC6A2 P23975 3/20 0.35
SLC6A4 P31645 3/20 0.35
SLC6A3 Q01959 2/20 0.35
CYP2D6 P10635 1/20 0.35
NOTUM Q6P988 5/20 0.33
AADAT Q8N5Z0 2/20 0.33
GOT1 P17174 1/20 0.33
KYAT1 Q16773 1/20 0.33
KYAT3 Q6YP21 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11638620 0.85 GAA (0.37) MTNR1AMTNR1BSLC6A2SLC6A4SLC6A3
SCHEMBL21172476 0.76 NOTUM (0.42) NOTUMAADATGOT1KYAT1KYAT3
SCHEMBL1600966 0.75 CA1 (0.48) MTNR1AMTNR1BCA1CA2ADH1B
SCHEMBL13853529 0.68 MTNR1A (0.56) MTNR1AMTNR1BCA1CA2
SCHEMBL11634064 0.67 LMNA (0.38) MTNR1AMTNR1BSLC6A2SLC6A4SLC6A3
SCHEMBL223608 0.65 MEN1 (0.54) NOTUMKMT2A
SCHEMBL8561458 0.65 EPHX2 (0.52) MTNR1AMTNR1BCA1CA2KMT2A
SCHEMBL8561461 0.65 EPHX2 (0.52) MTNR1AMTNR1BCA1CA2KMT2A
SCHEMBL8561460 0.65 EPHX2 (0.52) MTNR1AMTNR1BCA1CA2KMT2A
SCHEMBL7343944 0.64 ERN1 (0.36) HTR2AHTR2CKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed